TokenPost·
Edwards Lifesciences Lifts 2026 Constant-Currency Sales-Growth Outlook to About 11.5%
The company also raised its TAVR growth range and projected TMTT sales of $780 million to $790 million.
More news
- TokenPostTriton Declares $0.4765625 Dividend for Series F Preferred Shares
- TokenPostTriton International Declares $0.4296875 Series D Preference Dividend
- TokenPostTriton Sets $0.53125 Quarterly Dividend for Series A Preferred Shares
- TokenPostTKO Raises 2026 Forecast Again and Prices $1 Billion in Notes
- TokenPostFidelity FBTC leads with $199.87 million outflow as Bitcoin spot ETFs turn negative
- TokenPostMacro Analyst Roberto Rios Predicts Bitcoin Will Reach $300,000 This Cycle